Imugene Market Cap

Imugene has a market cap or net worth of 304.93 million as of January 17, 2025. Its market cap has decreased by -67.28% in one year.

Market Cap

304.93M

Enterprise Value

213.10M

Revenue

4.97M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.04

Market Cap Chart

Since September 17, 2002, Imugene's market cap has increased from 7.38M to 304.93M, an increase of 4,032.50%. That is a compound annual growth rate of 18.11%.

Market Cap History

Date	Market Cap	% Change
Jan 20, 2025	305.72M	11.10%
Dec 31, 2024	275.18M	-65.11%
Dec 29, 2023	788.60M	-15.31%
Dec 30, 2022	931.15M	-59.62%
Dec 31, 2021	2.31B	386.45%
Dec 31, 2020	474.09M	234.74%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CSL Limited	132.95B
Pro Medicus	26.99B
Cochlear	20.21B
Sonic Healthcare	13.38B
Telix Pharmaceuticals	8.74B
Ramsay Health Care	7.71B
Ansell	4.99B
Sigma Healthcare	4.48B

Market Cap Rankings